Comparative pharmacological profile and cardiovascular impact of classic and emergent mineralocorticoid antagonist receptors

Authors

  • Felipe Martinez Universidad Nacional de Córdoba, Instituto DAMIC - Fundación Rusculleda, Córdoba, Argentina
  • Eduardo R Perna Instituto de Cardiología J. F. Cabral, Corrientes, Argentina
  • Daniel Piskorz Instituto de Cardiología del Sanatorio Británico, Rosario, Santa Fe, Argentina

Keywords:

Arterial hypertension, Heart failure

Abstract

  • ALDOSTERONE IN THE PATHOPHYSIOLOGY OF ARTERIAL HYPERTENSION AND TARGET ORGAN DAMAGE
  • PHARMACOLOGICAL PROFILE OF MINERALOCORTICOID RECEPTOR ANTAGONISTS
  • IMPACT OF MINERALOCORTICOID RECEPTOR ANTAGONISTS ON ARTERIAL HYPERTENSION
  • HISTORY OF MINERALOCORTICOID RECEPTOR BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION
  • NON-STEROIDAL MINERALOCORTICOID RECEPTOR ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION
  • CARDIOVASCULAR IMPACT OF MINERALOCORTICOID RECEPTOR ANTAGONISTS IN HEART FAILURE
  • EVIDENCE IN HEART FAILURE WITH REDUCED EJECTION FRACTION
  • EVIDENCE IN HEART FAILURE WITH MILDLY REDUCED AND PRESERVED EJECTION FRACTION
  • EVIDENCE IN ACUTE HEART FAILURE
  • EVIDENCE IN MYOCARDIAL INFARCTION WITHOUT HEART FAILURE
  • MINERALOCORTICOID RECEPTOR ANTAGONISTS IN THE CONTEXT OF CURRENT HEART FAILURE TREATMENT
  • EVIDENCE IN PRIMARY PREVENTION OF HEART FAILURE.

Downloads

Published

2023-07-31

Issue

Vol. 52 (2023): Supplement: Mineralocorticoid antagonists in the cardio-renal-metabolic continuum: emerging role of finerenone

Section

Review Article

How to Cite

1.
Comparative pharmacological profile and cardiovascular impact of classic and emergent mineralocorticoid antagonist receptors. Rev. Fed. Arg. Cardiol. [Internet]. 2023 Jul. 31 [cited 2024 May 21];52:5-14. Available from: https://revistafac.org.ar/ojs/index.php/revistafac/article/view/508